Filana Therapeutics
FLNA
24 hedge funds and large institutions have $4.72M invested in Filana Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0.34% more ownership
Funds ownership: 32.92% → 33.26% (+0.34%)
8% less funds holding
Funds holding: 26 → 24 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
71% less capital invested
Capital invested by funds: $16.1M → $4.72M (-$11.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$167K |
| 2 |
BlackRock
New York
|
+$145K |
| 3 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$97.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$81.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$33.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$146K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$80K |
| 3 |
Morgan Stanley
New York
|
-$53.6K |
| 4 |
D.E. Shaw & Co
New York
|
-$24.9K |
| 5 |
Bank of New York Mellon
New York
|
-$10.7K |
FLNA Hedge Fund Activity: Q2 2018 in Review
24 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2018, worth a combined $4.72M — down 71% from $16.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of FLNA and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $167K. The largest seller was Deutsche Bank, exiting entirely with an estimated $146K sold.
- 24 institutional investors held Filana Therapeutics (FLNA) as of Q2 2018, down from 26 in Q1 2018.
- Funds reported $4.72M of Filana Therapeutics stock for Q2 2018, down 71% quarter-over-quarter.
- 2 funds opened new Filana Therapeutics positions in Q2 2018 and 4 closed out, a net change of -2 holders.
- The largest Filana Therapeutics buyer in Q2 2018 was Virtu Financial, an estimated $167K added.
- The largest Filana Therapeutics seller in Q2 2018 was Deutsche Bank, an estimated $146K sold.
Based on aggregated 13F filings for Q2 2018.